News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zosano Pharma, Inc. to Present Positive Phase 2 Results of Its Transdermal Patch for Osteoporosis



3/31/2009 10:56:32 AM

FREMONT, Calif.--(BUSINESS WIRE)--Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, today announced that an abstract detailing results of its Phase 2 study of ZP-PTH, a proprietary transdermal patch formulation of parathyroid hormone (PTH) for the treatment of established osteoporosis will be presented as a poster at the 8th International Symposium on Osteoporosis in Washington D.C.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES